BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37185327)

  • 61. Dabrafenib plus trametinib in patients with BRAF
    Wen PY; Stein A; van den Bent M; De Greve J; Wick A; de Vos FYFL; von Bubnoff N; van Linde ME; Lai A; Prager GW; Campone M; Fasolo A; Lopez-Martin JA; Kim TM; Mason WP; Hofheinz RD; Blay JY; Cho DC; Gazzah A; Pouessel D; Yachnin J; Boran A; Burgess P; Ilankumaran P; Gasal E; Subbiah V
    Lancet Oncol; 2022 Jan; 23(1):53-64. PubMed ID: 34838156
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Gliomas in children and adolescents: investigation of molecular alterations with a potential prognostic and therapeutic impact.
    Cabral de Carvalho Corrêa D; Tesser-Gamba F; Dias Oliveira I; Saba da Silva N; Capellano AM; de Seixas Alves MT; Dastoli PA; Cavalheiro S; Caminada de Toledo SR
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):107-119. PubMed ID: 34626238
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effectiveness-implementation hybrid-2 randomised trial of a collaborative Shared Care Model for Detecting Neurodevelopmental Impairments after Critical Illness in Young Children (DAISY): pilot study protocol.
    Long D; Gibbons K; Dow B; Best J; Webb KL; Liley HG; Stocker C; Thoms D; Schlapbach LJ; Wharton C; Lister P; Matuschka L; Castillo MI; Tyack Z; Bora S
    BMJ Open; 2022 Jul; 12(7):e060714. PubMed ID: 35840297
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
    Chen R; Cohen AL; Colman H
    Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Seizure prophylaxis following aneurysmal subarachnoid haemorrhage (SPSAH): study protocol for a multicentre randomised placebo-controlled trial of short-term sodium valproate prophylaxis in patients with acute subarachnoid haemorrhage.
    Chen Y; Fang M; Wu P; Xie Z; Wu H; Wu Q; Xu S; Li Y; Sun B; Pang B; Zheng N; Zhang J; Hu X; You C
    BMJ Open; 2022 May; 12(5):e057917. PubMed ID: 35508338
    [TBL] [Abstract][Full Text] [Related]  

  • 66. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Personalised, Rational, Efficacy-Driven Cancer Drug Dosing
    Tan BKJ; Teo CB; Tadeo X; Peng S; Soh HPL; Du SX; Luo VWY; Bandla A; Sundar R; Ho D; Kee TW; Blasiak A
    Front Digit Health; 2021; 3():635524. PubMed ID: 34713106
    [No Abstract]   [Full Text] [Related]  

  • 69. Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors.
    Schäfer N; Gielen GH; Rauschenbach L; Kebir S; Till A; Reinartz R; Simon M; Niehusmann P; Kleinschnitz C; Herrlinger U; Pietsch T; Scheffler B; Glas M
    J Transl Med; 2019 Mar; 17(1):96. PubMed ID: 30894200
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Embedding electronic patient-reported outcome measures into routine care for patients with stage III MELanoma (ePROMs-MEL): protocol for a prospective, longitudinal, mixed-methods pilot study.
    Dempsey K; Saw R; Bartula I; Lo S; Lawn C; Pennington T; Spillane A; Boyle F; Dong S; Dieng M; Milne D; Seaman L; Saks D; Lai-Kwon J; Thompson JR; Morton R
    BMJ Open; 2022 Dec; 12(12):e066852. PubMed ID: 36600423
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A contemporary perspective on the diagnosis and treatment of diffuse gliomas in adults.
    Roth P; Hottinger AF; Hundsberger T; Läubli H; Schucht P; Reinert M; Mamot C; Roelcke U; Pesce G; Hofer S; Weller M
    Swiss Med Wkly; 2020 Jun; 150():w20256. PubMed ID: 32557428
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Protocol for a process evaluation: face-to-face physiotherapy compared with a supported home exercise programme for the management of musculoskeletal conditions: the REFORM trial.
    Withers HG; Liu H; Glinsky JV; Chu J; Jennings MD; Hayes AJ; Starkey IJ; Palmer BA; Szymanek L; Cruwys JJ; Wong D; Duong K; Barnett A; Tindall MJ; Lucas BR; Lambert TE; Taylor DA; Sherrington C; Ferreira ML; Maher CG; Zadro JR; Harvey LA
    BMJ Open; 2022 Jul; 12(7):e057790. PubMed ID: 35790326
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol.
    McAuley SA; de Bock MI; Sundararajan V; Lee MH; Paldus B; Ambler GR; Bach LA; Burt MG; Cameron FJ; Clarke PM; Cohen ND; Colman PG; Davis EA; Fairchild JM; Hendrieckx C; Holmes-Walker DJ; Horsburgh JC; Jenkins AJ; Kaye J; Keech AC; King BR; Kumareswaran K; MacIsaac RJ; McCallum RW; Nicholas JA; Sims C; Speight J; Stranks SN; Trawley S; Ward GM; Vogrin S; Jones TW; O'Neal DN
    BMJ Open; 2018 Jun; 8(6):e020274. PubMed ID: 29886443
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
    Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
    J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A pilot study of therapeutic plasma exchange for serious SARS CoV-2 disease (COVID-19): A structured summary of a randomized controlled trial study protocol.
    Faqihi F; Alharthy A; Alodat M; Asad D; Aletreby W; Kutsogiannis DJ; Brindley PG; Karakitsos D
    Trials; 2020 Jun; 21(1):506. PubMed ID: 32513290
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches.
    Dhermain F
    Chin J Cancer; 2014 Jan; 33(1):16-24. PubMed ID: 24384237
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Advance of molecular subtyping and precise treatment for gliomas].
    Hua W; Mao Y
    Zhonghua Wai Ke Za Zhi; 2017 Jan; 55(1):63-66. PubMed ID: 28056258
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    Joseph S; Janakiraman R; Chacko G; Jayaraj R; Thomas M; Thomas M; Mukhopadhyay S
    BMJ Open; 2017 Oct; 7(10):e014824. PubMed ID: 29038175
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Whole genome analysis from microdissected tissue revealed adult supratentorial grade II-III gliomas are divided into clinically relevant subgroups by genetic profile.
    Hirose Y; Sasaki H; Miwa T; Ohba S; Ikeda E; Abe M; Ikeda S; Kobayashi M; Kawase T; Hasegawa M; Yoshida K
    Neurosurgery; 2011 Aug; 69(2):376-90. PubMed ID: 21358357
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Study protocol for the Healthier Wealthier Families (HWF) pilot randomised controlled trial: testing the feasibility of delivering financial counselling to families with young children who are identified as experiencing financial hardship by community-based nurses.
    Price AMH; Zhu A; Nguyen HNJ; Contreras-Suárez D; Schreurs N; Burley J; Lawson KD; Kelaher M; Lingam R; Grace R; Raman S; Kemp L; Woolfenden S; Goldfeld S
    BMJ Open; 2021 May; 11(5):e044488. PubMed ID: 34020976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.